Inducing sterile pyramidal neuronal death in mice to model distinct aspects of gray matter encephalitis.

(pre)frontal network dysfunction Diphtheria toxin Hippocampal learning and memory Magnetic resonance imaging Social cognition Thermography

Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
02 07 2021
Historique:
received: 11 05 2021
accepted: 07 06 2021
entrez: 3 7 2021
pubmed: 4 7 2021
medline: 15 12 2021
Statut: epublish

Résumé

Up to one person in a population of 10,000 is diagnosed once in lifetime with an encephalitis, in 50-70% of unknown origin. Recognized causes amount to 20-50% viral infections. Approximately one third of affected subjects develops moderate and severe subsequent damage. Several neurotropic viruses can directly infect pyramidal neurons and induce neuronal death in cortex and hippocampus. The resulting encephalitic syndromes are frequently associated with cognitive deterioration and dementia, but involve numerous parallel and downstream cellular and molecular events that make the interpretation of direct consequences of sudden pyramidal neuronal loss difficult. This, however, would be pivotal for understanding how neuroinflammatory processes initiate the development of neurodegeneration, and thus for targeted prophylactic and therapeutic interventions. Here we utilized adult male NexCreERT2xRosa26-eGFP-DTA (= 'DTA') mice for the induction of a sterile encephalitis by diphtheria toxin-mediated ablation of cortical and hippocampal pyramidal neurons which also recruits immune cells into gray matter. We report multifaceted aftereffects of this defined process, including the expected pathology of classical hippocampal behaviors, evaluated in Morris water maze, but also of (pre)frontal circuit function, assessed by prepulse inhibition. Importantly, we modelled in encephalitis mice novel translationally relevant sequelae, namely altered social interaction/cognition, accompanied by compromised thermoreaction to social stimuli as convenient readout of parallel autonomic nervous system (dys)function. High resolution magnetic resonance imaging disclosed distinct abnormalities in brain dimensions, including cortical and hippocampal layering, as well as of cerebral blood flow and volume. Fluorescent tracer injection, immunohistochemistry and brain flow cytometry revealed persistent blood-brain-barrier perturbance and chronic brain inflammation. Surprisingly, blood flow cytometry showed no abnormalities in circulating major immune cell subsets and plasma high-mobility group box 1 (HMGB1) as proinflammatory marker remained unchanged. The present experimental work, analyzing multidimensional outcomes of direct pyramidal neuronal loss, will open new avenues for urgently needed encephalitis research.

Identifiants

pubmed: 34215338
doi: 10.1186/s40478-021-01214-6
pii: 10.1186/s40478-021-01214-6
pmc: PMC8253243
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

121

Références

Front Neurol. 2021 Mar 22;12:631801
pubmed: 33828518
Front Behav Neurosci. 2016 Aug 11;10:151
pubmed: 27563287
JAMA Psychiatry. 2021 Jun 1;78(6):682-683
pubmed: 33769431
Vaccine. 2007 Aug 1;25(31):5771-92
pubmed: 17570566
Nat Neurosci. 2021 Feb;24(2):168-175
pubmed: 33257876
Nat Commun. 2017 Jan 24;8:14241
pubmed: 28117328
Genesis. 2005 Nov;43(3):129-35
pubmed: 16267821
J Neuroinflammation. 2016 Aug 24;13(1):194
pubmed: 27553758
Life Sci. 2019 Dec 1;238:116924
pubmed: 31606383
Front Behav Neurosci. 2014 May 16;8:181
pubmed: 24904333
Exp Neurol. 2007 May;205(1):207-13
pubmed: 17341420
J Neurovirol. 2012 Feb;18(1):30-44
pubmed: 22328242
EMBO Mol Med. 2012 Jun;4(6):528-39
pubmed: 22473874
Science. 2014 Oct 17;346(6207):318-22
pubmed: 25324381
Nat Commun. 2020 Mar 9;11(1):1313
pubmed: 32152318
Acta Paediatr. 2017 Mar;106(3):463-469
pubmed: 27886400
AJNR Am J Neuroradiol. 2018 Jun;39(6):994-1000
pubmed: 29301779
Magn Reson Med. 2019 Feb;81(2):962-975
pubmed: 30260028
J Clin Invest. 2018 Feb 1;128(2):734-745
pubmed: 29252214
FASEB Bioadv. 2019 Dec 23;2(1):18-32
pubmed: 32123854
World J Clin Cases. 2021 Feb 16;9(5):1058-1078
pubmed: 33644169
Neuroscientist. 2019 Apr;25(2):167-180
pubmed: 29865938
Mol Cell Biol. 2004 Sep;24(17):7636-42
pubmed: 15314171
Clin Microbiol Infect. 2019 Apr;25(4):415-421
pubmed: 30708123
J Neurosci. 2016 Jul 27;36(30):7946-56
pubmed: 27466339
J Neurosci. 2007 Oct 31;27(44):11925-33
pubmed: 17978032
Int J Mol Sci. 2009 Mar;10(3):1045-63
pubmed: 19399237
Mol Psychiatry. 2019 Oct;24(10):1489-1501
pubmed: 29426955
Behav Brain Res. 2007 Jan 10;176(1):4-20
pubmed: 16971002
Glia. 2017 Jun;65(6):931-944
pubmed: 28251674
Clin Infect Dis. 2013 Oct;57(8):1114-28
pubmed: 23861361
J Magn Reson Imaging. 2014 Mar;39(3):624-32
pubmed: 24068649
Infect Dis Clin North Am. 2018 Mar;32(1):145-162
pubmed: 29224854
Cereb Cortex. 2012 Jul;22(7):1473-86
pubmed: 21880656
Am J Pathol. 2013 Dec;183(6):1910-1917
pubmed: 24095925
NMR Biomed. 1997 Jun-Aug;10(4-5):171-8
pubmed: 9430344
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Ann Neurol. 2009 Jun;65(6):742-8
pubmed: 19557867
J Therm Biol. 2020 Apr;89:102529
pubmed: 32364975
Glia. 2016 Nov;64(11):2025-40
pubmed: 27470661
Neuroimage. 2009 Oct 1;47(4):1252-60
pubmed: 19520174
JAMA Neurol. 2021 May 1;78(5):536-547
pubmed: 33666649
Int J Infect Dis. 2018 May;70:131-136
pubmed: 29559369
J Neuropathol Exp Neurol. 2012 Jan;71(1):54-65
pubmed: 22157619
Biomarkers. 2017 Nov;22(7):635-642
pubmed: 27899037
J Neurol Sci. 2011 Jul 15;306(1-2):16-9
pubmed: 21546040
Virol J. 2011 May 09;8:209
pubmed: 21549011

Auteurs

Justus B H Wilke (JBH)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Martin Hindermann (M)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Amir Moussavi (A)

Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Kellnerweg 4, 37077, Göttingen, Germany.

Umer Javed Butt (UJ)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Rakshit Dadarwal (R)

Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Kellnerweg 4, 37077, Göttingen, Germany.
Georg August University, Göttingen, Germany.

Stefan A Berghoff (SA)

Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

Aref Kalantari Sarcheshmeh (AK)

Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Kellnerweg 4, 37077, Göttingen, Germany.

Anja Ronnenberg (A)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Svenja Zihsler (S)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Sahab Arinrad (S)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Rüdiger Hardeland (R)

Johann Friedrich Blumenbach Institute of Zoology & Anthropology, University of Göttingen, Göttingen, Germany.

Jan Seidel (J)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.

Fred Lühder (F)

Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.

Klaus-Armin Nave (KA)

Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

Susann Boretius (S)

Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Kellnerweg 4, 37077, Göttingen, Germany. SBoretius@dpz.eu.
Georg August University, Göttingen, Germany. SBoretius@dpz.eu.

Hannelore Ehrenreich (H)

Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. ehrenreich@em.mpg.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH